Stock MAGLE MAGLE CHEMOSWED HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Market Closed - Nasdaq Stockholm
Other stock markets
 05:40:07 14/05/2024 pm IST 		5-day change 1st Jan Change
32.4 SEK 0.00% Intraday chart for Magle Chemoswed Holding AB +1.25% +28.57%
18/04 Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
22/03 Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MAGLE GROUP REPORTS OUTCOME AND EXTENDS THE ACCEPTANCE PERIOD FOR THE PUBLIC TENDER OFFER TO THE SHAREHOLDERS OF AMNIOTICS
AQ
Bulletin from Annual General Meeting in Magle Chemoswed Holding AB (publ) held on the 25th of April 2024
AQ
Magle Chemoswed Q1 - Expansion by acquisition
AQ
Magle Chemoswed Holding Reports Financial Results For First Quarter 2024
AQ
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB
AQ
Magle Chemoswed Holding AB (publ) Releases Annual Report for 2023.
AQ
NOTICE OF ANNUAL GENERAL MEETING IN MAGLE CHEMOSWED HOLDING AB (PUBL)
AQ
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total
AQ
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed
AQ
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB
AQ
Magle Chemoswed Q4 - Ramp up in sales
AQ
Magle Chemoswed Holding AB (PUBL) – Publishes Full Year Report 2023 and Board’s Initial Proposal for Paying Dividends
AQ
Magle Chemoswed Q3 2023 - DSM business advancements
AQ
Magle Chemoswed Holding Reports Financial Results For Third Quarter 2023
AQ
Magle Group enters collaboration with Sirtex Medical to support the international commercialization of EmboCept® S DSM 50 µm
AQ
Magle Chemoswed Q2 2023 - Progress toward transition
AQ
Magle Chemoswed Holding Reports Financial Results For Second Quarter 2023
AQ
Magle Group initiates collaboration with leading German university hospital to explore synergies between EmboCept® S DSM 50 µm and immunotherapies
AQ
Magle Group applies for extended patent protection of its DSM technology in Europe
AQ
CHOSA Oncology AB out-license clinical-stage cancer vaccine candidate to Magle Group
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MAGLE Stock
  4. News Magle Chemoswed Holding AB
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW